title: Comment on Liu et al.'s article: "The true role of mRECIST guideline: does it really estimate viable tumor or merely improve accuracy in hepatocellular carcinoma response evaluation?".
authors.affiliation: Diagnostic and Interventional Radiology Dept, "Tzanio" General Hospital, Piraeus, Greece.
authors.forename: H
authors.initials: H
authors.lastname: Moschouris
authors.forename: A
authors.initials: A
authors.lastname: Papadatou
authors.forename: K
authors.initials: K
authors.lastname: Malagari
mesh_terms: D006528:Carcinoma, Hepatocellular / Q000628:therapy*; D016461:Chemoembolization, Therapeutic; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000628:therapy*; D008297:Male